Novartis India (NOVARTIND) — Board Meeting

📢 Key Event
Board approves acquisition of Minipress and Minipres trademarks from Pfizer for INR 1250 crores

🔄 What Changed
Approved acquisition of trademarks and IP rights for INR 1250 crores

🔮 What's Next
Transaction signing and closing to occur simultaneously

💡 Investor Takeaway
This acquisition adds valuable hypertension and BPH-focused brands to the portfolio, potentially driving future growth in these therapeutic areas.

Novartis India approved the acquisition of Pfizer's Minipress and Minipres trademarks and related IP rights for INR 1250 crores and 10,000. The transaction involves simultaneous signing and closing of an asset purchase agreement, with no related party connections or dilution impacts disclosed.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NOVARTIND ✨ Ask AI About This

About Novartis India Ltd (NOVARTIND)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹5,908.88 Cr P/E: 60.4 ROE: 11.9% ROCE: 16.7%

View full NOVARTIND stock details →

📡 Get AI alerts when NOVARTIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NOVARTIND — Free

💡 Ask AI about this filing

"How will this acquisition affect profitability?" "What is the expected revenue contribution?" "How does this compare to similar brand purchases?"

Ask AI Free →

📊 More NOVARTIND filings

See all NOVARTIND filings →

🔥 Also filed on 7 September 2026

521036 Source Industries (India) Ltd Annual Report 543578 Olatech Solutions Ltd Annual Report 512025 Asgard Alcobev Ltd Annual Report SIGACHI Sigachi Industries Ltd Corporate Action 503675 Wagend Infra Venture Ltd Annual Report 542864 Mount Housing & Infrastructure Ltd Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NOVARTIND files new disclosures

Track NOVARTIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NOVARTIND — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd